COMP <GO>
ERAS vs MIRM // EV/EBITDA & P/E VALUATION
Erasca Inc. (NASDAQ) VS. Mirum Pharmaceuticals Inc. (NASDAQ) • 15-METRIC TALLY: ERAS 0
— MIRM 5
■ METRIC PARITY
LAST: $14.05 (-2.09%) • MKT CAP: $5.02B
valuation
—
LAST: $85.74 (+0.87%) • MKT CAP: $5.52B
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ERAS VS. MIRM)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ERAS | MIRM | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -3.90% | -31.10 | MIRM | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -1.82% | 0.98% | -2.80 | MIRM | /fcf-yield <GO> |
| Operating Margin | — | -4.20% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | -4.50% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | 54.70% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 6.29 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 8/9 | -5.00 | MIRM | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 45.3 | 48.4 | -3.10 | MIRM | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.99 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 32.0x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.02B | $5.52B | -$500.2M | MIRM | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ERAS REV | MIRM REV | ERAS GROSS % | MIRM GROSS % | ERAS FCF | MIRM FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $394.5M | $521.3M | — | — | -$95.6M | $54.9M |
| FY 2024 | $502.8M | $336.9M | — | — | -$109.5M | $9.3M |
| FY 2023 | $396.3M | $186.4M | — | — | -$101.2M | -$79.3M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ERAS // BETA —
MIRM // BETA 0.99